TE_34891
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR36 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | -, CEACAM7 |
| Class | Chimeric, Intergenic |
| Coding | Annoated, Non-coding, Chimeric_truncated |
| Tumor-specific score | 217.53 |
| Counts of samples | TCGA_tumor:192; TCGA_normal:0; GTEx:0 |
| TSS | chr19(-):41742837 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_34891.21 | CEACAM7 | Chimeric | Non-coding | Non-coding | chr19(-):41677483,41677503,41686859,41687221,41694816,41694948,41742644,41742838 |
| teRNA_34891.22 | CEACAM7 | Chimeric | Non-coding | Non-coding | chr19(-):41684043,41684063,41686859,41687221,41694816,41694948,41742644,41742838 |
| teRNA_34891.23 | - | Intergenic | Non-coding | Non-coding | chr19(-):41738402,41738422,41742644,41742838 |
| teRNA_34891.24 | - | Intergenic | Non-coding | Non-coding | chr19(-):41715050,41715070,41717555,41717665,41742644,41742838 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
